| Literature DB >> 28758109 |
Yiwen Yu1,2, Yihui Yao2, Qinyun Weng3, Jingyi Li4, Jianwei Huang3, Yiqun Liao4, Fu Zhu3, Qifeng Zhao2, Xu Shen2, Jianjun Niu2.
Abstract
Staphylococcus aureus is a global epidemic pathogen that causes heavy disease burden. The aim of this study was to determine which globally known S. aureus lineages are currently present in a hospital of Xiamen. Therefore, the 426 S. aureus strains were detected by Melting Curve Analysis (MCA) and genotyped by Pulsed Field Gel Electrophoresis (PFGE) as well as Multicolor Melting Curve Analysis-Based Multilocus Melt Typing (MLMT). In addition, Multilocus Sequence Typing (MLST) was used to identify 108 representative strains. In light of eighteen antibiotics except for Vancomycin (by Broth Dilution Method), we used the Kirby-Bauer disc diffusion method to assess antibiotic susceptibility of 426 S. aureus strains. Finally, PFGE analysis revealed 14 different patterns with three major patterns (C10, C8, and C11) that accounted for 69.42% of all S. aureus strains, and MT-1~MT-5 occupied most part of the strains by MLMT. MLST revealed 25 different STs with the predominant types being ST239, ST59, and ST188. There have been 8 antibiotics that showed more than 50% resistance of all S. aureus strains. In summary, we found several of the lineages are predominant in our hospital. And antibiotic resistance is still a severe problem that needs to be controlled in clinic.Entities:
Mesh:
Year: 2017 PMID: 28758109 PMCID: PMC5516767 DOI: 10.1155/2017/1367179
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Demographics and sources of 426 S. aureus strains.
| Characteristics | Demographic outcomes | |
|---|---|---|
|
|
| |
|
| ||
| Male | 243 | 57.04% |
| Female | 183 | 42.96% |
|
| 65.96 ± 17.86 | |
| <30 | 13 | 3.05% |
| 30~ | 54 | 15.73% |
| 45~ | 76 | 17.84% |
| 60~ | 105 | 24.65% |
| 75 | 178 | 41.78% |
|
| ||
| Medical ward | 159 | 37.32% |
| Surgical ward | 199 | 46.71% |
| ICU | 68 | 15.96% |
|
| ||
| 0~9 | 251 | 58.9% |
| 10~19 | 83 | 19.48% |
| >20 | 92 | 21.60% |
|
| ||
| Blood | 13 | 3.05% |
| Bile | 1 | 0.23% |
| Secreta | 35 | 8.22% |
| Fester | 6 | 1.41% |
| Sputamentum | 344 | 80.75% |
| Pleural effusion | 1 | 0.23% |
| Synovial fluid | 1 | 0.23% |
| Drainage liquid | 7 | 1.64% |
| Throat swab | 8 | 1.88% |
| Midstream urine | 4 | 0.94% |
| Others | 6 | 3.05% |
Note. Values are mean ± SD of age.
Figure 1The PFGE cluster analysis of 108 representative S. aureus strains.
Figure 2MLMT analysis results of 426 S. aureus strains with PFGE. The number-frequency (%) of each MT is given together with the number of the corresponding PFGE clusters and the type and number of PFGE clusters of all the MTs obtained from the 426 strains. The size of the pies illustrates the relative number of MTs but not in a true scale.
Figure 3MST of 108 representative strains by MLST. MST: minimum spanning tree.
MLST, MLMT, and PFGE cluster analysis of 108 S. aureus strains.
| MLST | MLMT | PFGE clusters | PFGE types | Counts |
|---|---|---|---|---|
| ST1 | MT-10 | C8 | P44, 39, 31 | 3 |
| ST5 | MT-6 | C5, C8, C13 | P12; P23, 41, 43; P102 | 5 |
| ST6 | MT-1, MT3 | C8 | P36, 27, 30, 33, 35, 28, 37, 38, 29 | 9 |
| ST7 | MT-4 | C8 | P32, 20, 34, 26, 25, 40 | 6 |
| ST8 | MT-12 | C5, C6 | P9, 10; P16 | 3 |
| ST9 | MT-18 | C13 | P16 | 1 |
| ST15 | MT-8, MT-12 | C12 | P97, 98, 99, 100, 101 | 5 |
| ST20 | MT-11 | C5 | P13 | 1 |
| ST22 | MT-19 | C2 | P5 | 1 |
| ST25 | MT-14 | C7 | P17, 19 | 2 |
| ST30 | MT-9 | C3, C11 | P6; P87 | 2 |
| ST45 | MT-17 | C4 | P8 | 1 |
| ST59 | MT-2 | C11 | P95, 93, 96, 88, 90, 91, 89, 94, 92, 86, 87 | 11 |
| ST72 | MT-16 | C9 | P58 | 1 |
| ST88 | MT-7 | C14 | P104, 105, 106, 107, 108 | 5 |
| ST121 | MT-13 | C1 | P1, 2, 4 | 3 |
| ST188 | MT-5 | C8 | P45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56 | 12 |
| ST239 | MT-1 | C6, C10 | P15; P59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 74, 75, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86 | 27 |
| ST630 | MT-15 | C5; C9 | P11; P57 | 2 |
| ST837 | MT-13 | C1 | P3 | 1 |
| ST943 | MT-4 | C8 | P21, 22, 24 | 3 |
| ST965 | MT-20 | C8 | P42 | 1 |
| ST1281 | MT-11 | C5 | P14 | 1 |
| ST2631 | MT-11 | C10 | P76 | 1 |
| ST2805 | MT-14 | C7 | P18 | 1 |
Antibiotic susceptibility of 426 S. aureus strains (19 antibiotic agents).
| Antibiotics | Resistant | Intermediate | Susceptible | Resistance rate |
|---|---|---|---|---|
| Penicillin | 410 | 0 | 15 | 96.24% |
| Levofloxacin | 330 | 1 | 95 | 77.46% |
| Oxacillin | 301 | 0 | 124 | 70.66% |
| Norfloxacin | 292 | 3 | 130 | 68.54% |
| Ciprofloxacin | 288 | 10 | 127 | 67.61% |
| Gentamicin | 273 | 5 | 147 | 64.08% |
| Rifampicin | 271 | 1 | 153 | 63.62% |
| Azithromycin | 225 | 1 | 199 | 52.82% |
| Erythromycin | 201 | 5 | 199 | 47.18% |
| Clindamycin | 187 | 6 | 232 | 43.90% |
| Minocycline | 105 | 136 | 184 | 24.65% |
| Trimethoprim and Sulphamethoxazole | 46 | 207 | 173 | 10.80% |
| Chloramphenicol | 28 | 1 | 396 | 6.57% |
| Furantoin | 9 | 6 | 410 | 2.11% |
| Tigecycline | 3 | 11 | 411 | 0.70% |
| Quinupristin/Dalfopristin | 2 | 1 | 422 | 0.47% |
| Teicoplanin | 2 | 0 | 423 | 0.47% |
| Linezolid | 1 | 0 | 424 | 0.23% |
| Vancomycin | 0 | 0 | 425 | - |
Multiresistance phenotypes of 426 S. aureus strains resistant toother 18 antibiotics including Oxacillin.
| Resistance profile | Number (%) of strains |
|---|---|
| Oxacillin + 1 antibiotic | 3 (0.7%) |
| Oxacillin + 4 antibiotics | 25 (5.87%) |
| Oxacillin + 5 antibiotics | 4 (0.94%) |
| Oxacillin + 6 antibiotics | 52 (12.21%) |
| Oxacillin + 7 antibiotics | 65 (15.26%) |
| Oxacillin + 8 antibiotics | 23 (5.40%) |
| Oxacillin + 9 antibiotics | 74 (17.37%) |
| Oxacillin + 10 antibiotics | 40 (9.39%) |
| Oxacillin + 11 antibiotics | 13 (3.05%) |
| Oxacillin + 12 antibiotics | 3 (0.70%) |